There is the good news of coronavirus vaccine trials to be conducted in India. Pharma major Dr. Reddy’s Laboratories and Russia’s sovereign wealth fund RDIF have received approval from the Drugs Controller General of India (DCGI) to conduct an adaptive phase 2/3 human clinical trial for the Sputnik V vaccine in the country.

Coronavirus Pandemic: Clinical trials for Sputnik V to resume and to be held in India

sputnik-v-trails-allowed-by-dcgi

Sputnik V Trails Allowed By Dcgi, News on Sputnik V Trails Allowed By Dcgi, stories on Sputnik V Trails Allowed By Dcgi, articles on Sputnik V Trails Allowed By Dcgi, Sputnik V Trails Allowed By Dcgi stories at Wion, Sputnik V Trails Allowed By Dcgi news, Sputnik V Trails Allowed By Dcgi latest news

sputnik v-trails-allowed-by-dcgi

Coronavirus Pandemic: Clinical trials for Sputnik V to resume and to be held in India